CAS 263251-78-1

Fórmula: C24H32N6O11

InChI: InChI=1S/C24H32N6O11/c25-9-2-1-3-15-23(37)29-17(22(36)26-12-20(33)34)8-10-41-18-6-4-13(30(39)40)11-14(18)21(35)27-16(24(38)28-15)5-7-19(31)32/h4,6,11,15-17H,1-3,5,7-10,12,25H2,(H,26,36)(H,27,35)(H,28,38)(H,29,37)(H,31,32)(H,33,34)/t15-,16-,17-/m0/s1

Chave InChI: DVJXNXPFYJIACK-ULQDDVLXSA-N

SMILES: C1COC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)NCC(=O)O)CCCCN)CCC(=O)O

Tavilermide

CAS: 263251-78-1

Tavilermide

Fórmula: C₂₄H₃₂N₆O₁₁

Pureza: ≥98%

Peso molecular: 580.54

Ref: 54-BUP22178

Tavilermide

CAS: 263251-78-1

Fórmula: C₂₄H₃₂N₆O₁₁

Pureza: 98%

Peso molecular: 580.5445

Ref: IN-DA00BJXG

Tavilermide

CAS: 263251-78-1

Tavilermide is a conjunctival diagnostic agent that is used to identify inflammatory diseases. It is also an anti-inflammatory agent. Tavilermide has been shown to have a safety profile and to be effective in relieving symptoms of certain inflammatory diseases, such as ocular and nasal allergies, asthma, eczema, and dermatitis. Tavilermide is a conjugate of tyrosine kinase inhibitor peptides with glycoconjugates. The presence of the glycoconjugates increases the half-life and bioavailability of the active substances in the eye. This allows for less frequent dosing than other diagnostic agents.

Fórmula: C₂₄H₃₂N₆O₁₁

Pureza: Min. 98 Area-%

Peso molecular: 580.54 g/mol

Ref: 3D-NKA25178

Tavilermide

CAS: 263251-78-1

Tavilermide (MIM-D3) is a selective TrkA agonist, a cyclic mimetic, which can be used to study dry keratoconjunctivitis and dry eye syndrome.

Fórmula: C₂₄H₃₂N₆O₁₁

Pureza: 98.98%

Cor e Forma: Solid

Peso molecular: 580.5445

Ref: TM-T17000